Marina Gray, APRN
Psychiatric/Mental Health · Searcy, ARNPI 1003531518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 34.9% of the total. Reporting peaked in 2023 at $1,988 and has fallen 55.9% since, to $876 in 2025.
Across 202 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$489
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$407
- Neurocrine Biosciences, Inc.$247
- Vanda Pharmaceuticals Inc.$239
- Teva Pharmaceuticals USA, Inc.$178
- plus $953 from 11 others
What the payments were for
- Food & beverage$3,862100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,348 |
| Otsuka America Pharmaceutical, Inc. | 27 | $489 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $407 |
| Neurocrine Biosciences, Inc. | 13 | $247 |
| Vanda Pharmaceuticals Inc. | 20 | $239 |
| Teva Pharmaceuticals USA, Inc. | 9 | $178 |
| Johnson & Johnson | 6 | $134 |
| Supernus Pharmaceuticals, Inc. | 6 | $134 |
| Ironshore Pharmaceuticals Inc. | 6 | $122 |
| Lundbeck LLC | 6 | $114 |
| Alkermes, Inc. | 5 | $108 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Tris Pharma Inc | 4 | $84 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Idorsia Pharmaceuticals US Inc | 1 | $40 |
| Corium, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
How this compares
$3,862 in reported general payments places this provider in the 85th percentile of 359 psychiatric/mental health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 12 | $14,667 |
| Aripiprazole | 72 | $6,396 |
| Duloxetine Hcl | 109 | $2,975 |
| Desvenlafaxine ErDesvenlafaxine | 12 | $1,712 |
| Quetiapine Fumarate | 61 | $859 |
| Hydroxyzine Hcl | 37 | $697 |
| Trazodone Hcl | 74 | $636 |
| Clonazepam | 60 | $581 |
| Buspirone Hcl | 44 | $480 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 41 | $469 |
| Olanzapine | 14 | $421 |
| Gabapentin | 30 | $358 |
| Bupropion XlBupropion Hcl | 27 | $295 |
| Oxcarbazepine | 12 | $286 |
| Sertraline Hcl | 49 | $250 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,348 | $14,66712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 359 psychiatric/mental health providers in Arkansas.
Other psychiatric/mental health in Searcy
- Sarah RamseySearcy$12K
- Stephanie ParishSearcy$9K
- Stephanie BohannonFayetteville$32K
- Michael BelinSherwood$30K
- Mallori LevengoodPine Bluff$11K
- Jennifer PenneFayetteville$11K
- Elizabeth HardyTexarkana$8K
- Tammy HawkinsJonesboro$8K
- Cara MeckfesselLittle Rock$8K
- Sakinah ShawHot Springs$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.